Medicine and Dentistry
Cytoreductive Surgery
100%
Hyperthermic Intraperitoneal Chemotherapy
94%
Neoplasm
40%
Colorectal Liver Metastasis
33%
Overall Survival
33%
Hepatectomy
32%
Colorectal Carcinoma
30%
Peritoneum Metastasis
29%
Peritoneum Mesothelioma
26%
Pancreas Adenocarcinoma
26%
Recurrent Disease
23%
Hand Assisted Laparoscopy
21%
Diverticulitis
21%
Cancer
20%
Hepatocellular Carcinoma
19%
CA-125
19%
Pancreaticoduodenectomy
19%
Carcinomatous Peritonitis
19%
Malignant Neoplasm
18%
Intraperitoneal Chemotherapy
17%
Peritoneum Cancer
15%
Adenocarcinoma
15%
Metastatic Carcinoma
14%
Lymphocyte
14%
Neutrophil
14%
Diseases
13%
Abdominal Cancer
13%
Colon Diverticulosis
13%
Acute Appendicitis
13%
Elderly Patient
13%
Lymph Node Metastasis
13%
Postoperative Complication
12%
Primary Tumor
11%
Metastasectomy
11%
Retrospective Study
10%
Propensity Score Matching
10%
Neoadjuvant Therapy
10%
Liver Transplantation
8%
Appendix Tumor
8%
Adjuvant Therapy
8%
Liver Metastasis
8%
Recurrence Free Survival
7%
Long Term Survival
7%
Surgeon
7%
Esophagectomy
7%
Platelet
7%
Germline Mutation
7%
Postoperative Pain
7%
Colon
7%
Sorafenib
7%
Keyphrases
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
95%
Cytoreductive Surgery
94%
Colorectal Liver Metastases
36%
Resection
23%
Hand-assisted Laparoscopic Surgery
23%
Peritoneal Metastasis
22%
Pancreatic Ductal Adenocarcinoma
21%
Overall Survival
21%
Systemic Chemotherapy
20%
Peritoneal Mesothelioma
19%
Peritoneal Cancer Index
19%
Carbohydrate Antigen 125 (CA125)
17%
Acute Diverticulitis
17%
Propensity Score Matching
15%
Liver Resection
15%
Peritoneal Carcinomatosis
15%
Peritoneal Surface Malignancy
15%
Medical Center
14%
Tumor
14%
Pancreaticoduodenectomy
13%
CA-125 Levels
13%
Appendiceal
13%
Acute Appendicitis
13%
Laparoscopic Pancreaticoduodenectomy
13%
Colonic Diverticulitis
13%
National Surgical Quality Improvement Program (NSQIP)
13%
Hepatocellular Carcinoma
13%
Elderly Patients
13%
Operative
12%
Postoperative Day
11%
Recurrence-free Survival
10%
Pancreatic Adenocarcinoma
10%
Colorectal Cancer
10%
Surgical Resection
10%
Laparoscopic Approach
10%
Neoadjuvant Therapy
10%
Postoperative Outcomes
10%
Surgical Management
9%
Primary Tumor
9%
Operative Time
9%
Survival Prediction
9%
Readmission
9%
Recurrence Pattern
9%
Diverticulitis
9%
Adenocarcinoma
9%
Median Overall Survival
9%
Intraperitoneal Chemotherapy
9%
Colorectal Resection
8%
Patient Selection
8%
Colorectal Peritoneal Metastases
8%